GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Issuance of Stock

Genome (XKRX:314130) Issuance of Stock : ₩81 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Genome Issuance of Stock?

Genome's Issuance of Stock for the three months ended in Dec. 2023 was ₩26 Mil.

Genome's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 was ₩81 Mil.

Genome Issuance of Stock Historical Data

The historical data trend for Genome's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genome Issuance of Stock Chart

Genome Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Issuance of Stock
- 211.84 71,449.75 1,247.75 126.83

Genome Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.15 0.52 54.90 0.33 25.74

Genome Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genome Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Genome's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Genome (XKRX:314130) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Issuance of Stock
Comparable Companies
XKRX:078160 XKRX:138610 XKRX:214260 XKRX:321550 XKRX:084990 XKRX:235980 XKRX:174900 XKRX:046210 XKRX:226950 XKRX:278650 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Innovalley A-801, Pangyo-ro 253, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
Website
http://www.genomecom.co.kr
Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

Genome (XKRX:314130) Headlines

No Headlines